Phase 1 Lymphoma, Large B-Cell, Diffuse Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma

Lymphoma, Non-HodgkinLymphoma, B-CellLymphoma, Large B-Cell, Diffuse

Janssen Research & Development, LLC439 enrolled32 locationsNCT05421663

Recruiting

Phase 1

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

Lymphoma, B-CellChronic Lymphocytic Leukemia (CLL)Lymphoma, Non-Hodgkin (NHL)+1 more

Umoja Biopharma106 enrolled8 locationsNCT06528301

Recruiting

Phase 1Phase 2

A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies

Lymphoma, Non-HodgkinLymphoma, B-CellLarge B-cell Lymphoma+3 more

Cancer Research UK84 enrolled7 locationsNCT06045910